Granulocyte Colony Stimulating Factor ( DrugBank: Granulocyte Colony Stimulating Factor )

6 diseases

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01825551 (ClinicalTrials.gov)	November 2012	13/3/2013	The Effect of GCSF in the Treatment of ALS Patients	The Effect of Granulocyte Colony Stimulating Factor(GCSF) in the Treatment of Amyotrophic Lateral Sc ...	Amyotrophic Lateral Sclerosis	Drug: Granulocyte Colony Stimulating Factor;Drug: Placebo	Tehran University of Medical Sciences	NULL	Completed	18 Years	85 Years	Both	40	Phase 2/Phase 3	Iran, Islamic Republic of
2	NCT00397423 (ClinicalTrials.gov)	December 2006	8/11/2006	G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response	Granulocyte-Colony Stimulating Factor Treatment for Amyotrophic Lateral Sclerosis: A Randomized Cont ...	Amyotrophic Lateral Sclerosis	Drug: Granulocyte Colony Stimulating Factor;Drug: NS	Peking University	NULL	Completed	18 Years	65 Years	Both	40	Phase 2	China

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-006395-37-GB (EUCTR)	06/09/2007	31/07/2007	A randomised, multi-centre feasibility trial in AL Amyloidosis, comparing CTD with SCT in patients w ...	A randomised, multi-centre feasibility trial in AL Amyloidosis, comparing CTD with SCT in patients w ...	The medical condition to be investigated is systemic AL Amyloidosis, a disorder of protein folding i ...	Product Name: Cyclophosphamide INN or Proposed INN: CYCLOPHOSPHAMIDE Product Name: Cyclophosphamide INN ...	Joint UCLH and UCL Biomedical Research Unit	NULL	Not Recruiting			Female: yes Male: yes	48	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United Kingdom

臨床試験数 : 163 / 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01538862 (ClinicalTrials.gov)	February 2012	20/2/2012	Efficacy of Granulocyte Colony Stimulating Factor(GCSF) In Patients With Dystrophic Epidermolysis Bu ...	Efficacy of Granulocyte Colony Stimulating Factor(GCSF) In Patients With Dystrophic Epidermolysis Bu ...	Dystrophic Epidermolysis Bullosa	Drug: Granulocyte Colony Stimulating Factor (GCSF)	Vanderbilt University Medical Center	NULL	Completed	N/A	N/A	All	7	Phase 2	United States

臨床試験数 : 11 / 薬物数 : 23 - (DrugBank : 12) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 35

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01302171 (ClinicalTrials.gov)	August 2010	21/2/2011	Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy	Randomised Controlled Trial to Compare the Effects of G-CSF (Granocyte™) and Autologous Bone Marrow ...	Dilated Cardiomyopathy	Drug: granulocyte colony stimulating factor (GCSF);Procedure: bone marrow mononuclear cells	Barts & The London NHS Trust	Royal Brompton & Harefield NHS Foundation Trust;University College London Hospitals	Completed	18 Years	80 Years	Both	60	Phase 2	United Kingdom

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-003842-18-IT (EUCTR)	08/01/2019	19/11/2018	Gene therapy study using a frozen formulation of OTL-103 in patients with Wiskott-Aldrich Syndrome ( ...	A Single Arm, Open Label Clinical Study of Haematopoietic Stem Cell Gene Therapy with Cryopreserved ...	Wiskott-Aldrich Syndrome MedDRA version: 20.0;Level: PT;Classification code 10061598;Term: Immunodef ...	Product Name: OTL-103 Dispersion for Infusion Product Code: OTL-103 INN or Proposed INN: Other hematol ...	Orchard Therapeutics Ltd.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	6	Phase 3	Italy

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-OOC-15005862	2015-01-01	2015-01-19	The clinical study of the treatment by Granulocyte colony stimulating factorfor idiopathic pulmonary ...	An Open-label, parallel, randomized controlled clinical study of the treatment by Granulocyte colony ...	idiopathic pulmonary fibrosis	treatment group:subcutaneous injection of Granulocyte colony stimulating factortermly;control group: ...	Shanghai Pulmonary Hospital	NULL	Recruiting	50	80	Both	treatment group:50;control group:50;		China